LLY vs MACIU · P/E 39, rev $22.97B vs $181.0M cap
Eli Lilly and Company (LLY) versus Melar Acquisition Corp. I Unit (MACIU) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Melar Acquisition Corp. I Unit (MACIU) is a shell companies company listed on US.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
MACIU does not have a complete income-statement cache yet.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. MACIU currently screens at market cap $181.0M.
Not investment advice. Open the LLY and MACIU stock pages for the full models.
Not investment advice.